Predict your next investment

Cardiacbooster company logo
HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing
cardiacbooster.com

See what CB Insights has to offer

Founded Year

2018

Stage

Incubator/Accelerator | Alive

Total Raised

$330K

About Cardiacbooster

Cardiacbooster is a medical device company developing percutaneous left ventricular assist devices.

Cardiacbooster Headquarter Location

Geert Grooteplein Zuid 10

Nijmegen, 6525GA,

Netherlands

Latest Cardiacbooster News

CardiacBooster and founder Daniel van Dort featured in Innovation Origins article

Jun 28, 2021

CardiacBooster and her founding physician inventor, Daniel van Dort, were recently featured in an Innovations Origins article . The article describes nicely how it all started, what motivation stands both behind founder and company and what the ambition is for the future – improving the lives of patients in need of cardiac support by bringing impactful innovation to the clinic.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cardiacbooster

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cardiacbooster is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,401 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. Excludes CDMOs/CMOs. *Columns updated as regularly as possible.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.